Previous Article | Next Article ![]()
Molecular and Cellular Biology, March 2007, p. 2003-2013, Vol. 27, No. 6
0270-7306/07/$08.00+0 doi:10.1128/MCB.01462-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Graduate School of Life Science, University of Hyogo, 3-2-1 Koto, Kamigori, Hyogo 678-1297,1 Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681,2 Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan3
Received 8 August 2006/ Returned for modification 22 September 2006/ Accepted 2 January 2007
|
|
|---|
|
|
|---|
and proliferating cell nuclear antigen (PCNA), contain a common 8-bp palindromic sequence (5'-TATCGATA-3'), named the DNA replication-related element (DRE) (12). These DREs are required for promoter activities both in cultured cells and in flies in vivo (41). We have purified the DRE-binding factor (DREF) from cultured Drosophila cells, consisting of an 86-kDa polypeptide homodimer specifically binding to DRE, and isolated a cDNA (12, 13). The importance of Drosophila DREF in development has been demonstrated from studies using transgenic flies (11, 14, 44). For example, ectopic expression of Drosophila DREF in eye imaginal disc cells behind the morphogenetic furrow, which are normally postmitotic, induced ectopic DNA synthesis and apoptosis and abolished photoreceptor specifications (11). More recently, we and Hyun et al. have succeeded in knocking down Drosophila DREF expression in various tissues (16, 45). Decreased levels of DREF in developing wing and eye imaginal discs were associated with reduction in wing size with smaller cells and drastically aberrant small and rough eyes, respectively. These lines of evidence indicate that the Drosophila DRE/DREF system performs important roles in regulation of cell growth as well as cell proliferation during development. How many and what kind of genes other than those described above are under control of the Drosophila DRE/DREF system? Immunostaining of polytene chromosomes of salivary glands revealed that Drosophila DREF binds to hundreds of loci (8, 10), and recent computational analysis of core promoters in the Drosophila genome showed DRE to be the second most frequent motif apparent in core promoter sequences from 60 to +40, with a frequency higher than those for the TATA box and initiator sequences (4, 24). Already, we and others have demonstrated that the Drosophila DRE/DREF system regulates a number of Drosophila genes involved in DNA replication as well as those involved in cell cycle progression through S (dE2F1) (33) and G2/M (D-raf, D-myb, and cyclin A) phases (25, 29, 34).
Despite much progress in understanding the Drosophila DRE/DREF system, little is known about the corresponding mammalian DRE/DREF system. We have identified a human homologue of DREF (hDREF) and a binding consensus sequence [hDRE; 5'-TGTCG(C/T)GA(C/T)A-3'] (26). Our previous study showed that the expression level of hDREF is elevated during the G1-to-S transition and reaches a maximum at S phase in normal human fibroblasts. Moreover, RNA interference experiments targeting hDREF pointed to an important role in cell cycle progression. We also demonstrated that the histone H1 gene carrying an hDRE is regulated by hDREF (26). However, other functions and target genes of hDREF remain to be clarified.
The ribosome is a vital organelle which is responsible for protein synthesis in all living organisms. Production of mature ribosomes consisting of rRNAs and ribosomal proteins (RPs) requires a highly coordinated multistep process, and many reports have shown that the initiation of rRNA transcription is tightly linked to cell cycle progression, with synthesis of rRNA increasing during G1 phase, becoming maximal in S and G2 phases, and being repressed during mitosis (7, 20, 22). Similarly, coordinated synthesis of all RP genes during the cell cycle, leading to the precise and equimolar production of the 79 RPs necessary for ribosome biogenesis and translation control, is required to support adequate protein synthesis (37). Despite the obvious importance of RP gene expression for cell proliferation, only a limited number of experimental studies of mammalian RP gene promoter structures and transcriptional regulation have been performed so far. Recent determination of a complete map and nucleotide sequences now allows searches for regulatory elements common to a number of human RP genes, and Perry has identified "box A" [5'-TCTCGCGA(G/T)-3'] as one of the most conserved sequences in RP gene promoters (28).
In this report, we document evidence that hDREF is a transcription factor essential for cell proliferation which binds to box A and positively regulates a set of human RP genes. We also show that mammalian RP gene expression is induced during late G1 and S phases and that fluctuation of hDREF expression during the cell cycle is in line with cell cycle-dependent expression of RP genes.
|
|
|---|
To create a lentivirus vector expressing HA-hDREF directed by the human metallothionein gene (MTIIA) promoter, the EF-1
gene promoter in pCSII-EF-MCS-IRES2-Venus was swapped with the 765 to +55 region of the MTIIA gene and a cDNA encoding HA-hDREF was inserted. Lentiviruses expressing shRNA against hDREF or RPS6 were prepared as follows. A pair of 48- or 49-base oligonucleotides containing a 20-nucleotide targeting sequence, a spacer sequence which provided a loop structure, and an extra sequence to facilitate cloning were annealed and cloned into an attL-containing pENTER/U6 plasmid (Invitrogen). The cassette containing the U6 promoter and shRNA target sequence was then transferred to a self-inactivating lentivirus vector (pCS-RfA-EG), generating pCS-U6-shRNA-EG.
Luciferase reporter plasmids containing the promoter region of RPS6 (RPS6-310+43/pGL3) were obtained as follows. The promoter region of human RPS6 (310 to +43) was amplified by PCR with genomic DNA from HFF cells as a template and was ligated between the Asp718 and BglII sites of the pGL3 basic vector (Promega). RPL10A-193+17/pGL3 and RPL12-277+57/pGL3, containing the upstream regions from position 193 to position +17 of RPL10A and from position 277 to position +57 of RPL12, respectively, were created by the same procedures as RPS6. Linker insertion mutants of the luciferase reporter plasmids were created by digesting wild-type reporter plasmids with NruI and then ligating those with a 12-mer EcoRI linker (TaKaRa). Base substitution derivatives (mut1, mut2, mut3, mut4, and mut5) and a deletion derivative (
hDRE) of RPS6-310+43/pGL3 were generated as follows. An upstream region of RPS6 was amplified by PCR using primer sets containing a 3-bp substitution mutation or a 10-bp deletion mutation with RPS6-310+43/pGL3 as a template and inserted between the Asp718 and BglII sites of the pGL3 basic vector. All plasmids were isolated and purified using a QIAGEN plasmid Midi kit (QIAGEN).
Oligonucleotides.
Double-stranded oligonucleotides containing hDRE-like sequence in the promoter region of the human RPS6 gene (RPS6) (position at 56 to 22 with respect to the transcriptional start site) and its base substitution derivative sequences (mut1, mut2, mut3, mut4, and mut5) or a deletion derivative sequence (
hDRE), shown below, were synthesized. The sequences used are as follows: for RPS6-hDRE, 5'-GTACTTCTGCTCATCTCGCGAGAACTGAAAGCGCC-3' and 5'-GGCGCTTTCAGTTCTCGCGAGATGAGCAGAAGTAC-3'; for mut1, 5'-GTACTTCTGCctgTCTCGCGAGAACTGAAAGCGCC-3' and 5'-GGCGCTTTCAGTTCTCGCGAGAcagGCAGAAGTAC-3'; for mut2, 5'-GTACTTCTGCTCA ctcCGCGAGAACTGAAAGCGCC-3' and 5'-GGCGCTTTCAGTTCTCGCGgagTGAGCAGAAGTAC-3'; for mut3, 5'-GTACTTCTGCTCATCTtatGAGAACTGAAAGCGCC-3' and 5'-GGCGCTTTCAGTTCTCataAGATGAGCAGAAGTAC-3'; for mut4, 5'-GTACTTCTGCTCATCTCGCagaAACTGAAAGCGCC-3' and 5'-GGCGCTTTCAGTTtctGCGAGATGAGCAGAAGTAC-3'; for mut5, 5'-GTACTTCTGCTCATCTCGCGAGggtTGAAAGCGCC-3' and 5'-GGCGCTTTCAaccCTCGCGAGATGAGCAGAAGTAC-3'; and for
hDRE, 5'-CCGTACTTCTGCTCAACTGAAAGCGCCTAT-3' and 5'-ATAGGCGCTTTCAGTTGAGCAGAAGTACGG-3'. The nucleotide sequences corresponding to the 10-bp hDRE are shown in bold letters, with nucleotides substituted for the wild-type sequence in lowercase. These oligonucleotide pairs were used to create base substitution mutant RPS6 promoter-luciferase reporter plasmids (RPS6-310+43/pGL3) and also as competitors in electrophoretic gel mobility shift assays (EMSA). Double-stranded oligonucleotides containing hDRE in the promoter region of the human histone H1 gene were described previously (26).
Oligonucleotide pairs used for PCR amplification of the promoter regions of RPS6 (310 to +43), RPL10A (193 to +17), and RPL12 (277 to +57) were synthesized. The sequences used are as follows: for RPS6, 5'-ATAggtaccGTCAGATGCAAAGTG-3' and 5'-ATATagatctCTTGAAGCAGCTGAACGCCT-3'; for RPL10A, 5'-ATAggtaccCGACAACTCTGTGGGTTACCG-3' and 5'-ATATagatctATGGCTTCTCACGCCGCGCTA-3'; and for RPL12, 5'-ATAggtaccGGGTGACACTCACGATAAAGG-3' and 5'-ATATagatctATTCGGGACGACCGAAGGAAG-3'. Recognition sites for Asp718 and BglII are denoted by lowercase letters.
PCR primer pairs were synthesized and used for semiquantitative reverse transcriptase PCR (RT-PCR) for transcripts of the following genes: hDREF, 5'-TGGTGGAGGAGCTGAGCAACTT-3' and 5'-AGAAACACCTGCTCG TCCACGT-3'; RPS6, 5'-TGGATGCAAATCTGAGCGTT-3' and 5'-TTCTTTATTTTTCTTGGTACGCT-3'; RPL10A, 5'-AGCAGCACTGTGACGAGGCTA-3' and 5'-TTTGGCCACCATGTTTTCGTTG-3'; RPL12, 5'-AGTCGTATACCTGAGGTGCACCGGA-3' and 5'-GCCATCAACATTACAGCCCACTGAC-3'; and ACTB (ß-actin), 5'-CGCTCGTCGTCGACAACGGCTC-3' and 5'-TCAAACATGATCTGGGTCATCTTCTC-3'. PCR primer pairs for the human histone H1 gene were described previously (26).
PCR primer pairs used in chromatin immunoprecipitation (ChIP) assays are as follows: RPS6 proximal, 5'-ACAACCTCAGACCCACACCCAACCG-3' and 5'-ATATAGATCTCTTGAAGCAGCTGAACGCCT-3'; RPS6 distal, 5'-ATGTGCCTTTGGAAGGCCTTAGCAC-3' and 5'-CAAAGTGTGTGGTGCTAATAGTCCCA-3'; RPL10A proximal, 5'-ATAGGTACCCGACAACTCTGTGGGTTACCG-3' and 5'-ATATAGATCTATGGCTTCTCACGCCGCGCTA-3'; RPL10A distal, 5'-GTGGGATACCAGGCACACAACGTGG-3' and 5'-TCTAGTCTTCTAGGTCATTCTAGTC-3'; RPL12 proximal, 5'-ATCTCTAGCTTCAGCGCACCGCGGT-3' and 5'-ATATAGATCTATTCGGGACGACCGAAGGAAG-3'; and RPL12 distal, 5'-AACATTCTTCTTACTTGAAGGGTGC-3' and 5'-GTGCTGGCTCAGTCCCTCACAATCT-3'.
Oligonucleotide pairs used for constructing lentivirus vectors (pCS-U6-shRNA-EG) expressing shRNAs against hDREF (si3 and si4), shRNAs against RPS6 (RPS6-#1 and RPS6-#2), and scramble shRNAs as a negative control were as follows: for si3, 5'-caccGCAACAACCACCACCTCATGCccacaccGCATGAGGTGGTGGTTGTTG-3' and 5'-aaaaCAACAACCACCACCTCATGCggtgtggGCATGAGGTGGTGGTTGTTGc-3'; for si4, 5'-caccgCAACTTCAAGTCCCAGAAGGccacaccCCTTCTGGGACTTGAAGTTG-3' and 5'-aaaaCAACTTCAAGTCCCAGAAGGggtgtggCCTTCTGGGACTTGAAGTTGc-3'; for RPS6-#1, 5'-caccgCGTCTTGTTACTCCACGTccacaccACGTGGAGTAACAAGACGc-3' and 5'-aaaaGCGTCTTGTTACTCCACGTggtgtggACGTGGAGTAACAAGACGC-3'; for RPS6-#2, 5'-caccgGAACAAATTGCGAAGAGAccacaccTCTCTTCGCAATTTGTTCC-3' and 5'-aaaaGGAACAAATTGCGAAGAGAggtgtggTCTCTTCGCAATTTGTTCc-3'; and for scramble, 5'-caccgcgcgctttgtaggattcgccacacccgaatcctacaaactacaaa-3' and 5'-aaaaggcgctttgtaggatacgggtgtggcgaatcctacaaagcgcgc-3'. Sense and antisense target sequences against hDREF or RPS6 mRNAs are shown by capital letters.
To construct a plasmid expressing a si4 knockdown-resistant hDREF, the following oligonucleotides were used: 5'-tggaggagctgagTaaTttTaaAAGccAaaAagtgcttggcctca-3' and 5'-tgaggccaagcactTttAggCTTttAaaAttActcagctcctcca-3'. The substituted nucleotides are indicated by capital letters.
Cell culture. HeLa cells were cultured as described previously (42). HFF cells, generated by infection with a retrovirus expressing hTERT (a gift from T. Kiyono) (21), were maintained in Dulbecco's modified Eagle's medium (high glucose) with 10% fetal bovine serum and antibiotic-antimycotic (Sigma) at 37°C under 5% CO2.
Preparation and transduction of recombinant lentiviruses. The plasmids used in preparation of recombinant lentiviruses were described previously (42). Recombinant lentiviruses were produced as follows. 293FT cells were cultured according to the manufacturer's instructions (Invitrogen). For overexpression of hDREF, 7 µg of pCSII-EF-hDREF-IRES2-Venus, 5 µg of pCAG-HIVgp, and 4 µg of pCMV-VSV-G-RSV-Rev were cotransfected. For knockdown against hDREF or RPS6, 13 µg of pCS-U6-shRNA-EG, 5 µg of pCAG-HIVgp, and 4 µg of pCMV-VSV-G-RSV-Rev were cotransfected. Supernatants containing the recombinant lentiviruses were collected 48 h after DNA transfection, passed through a 0.45-µm filter, and used for transduction experiments. HFF cells were transduced with indicated lentiviruses for 6 h, washed with phosphate-buffered saline (PBS) once, and used for the experiments. Transduction efficiencies were determined by detecting green fluorescent protein (GFP) or Venus, a derivative of yellow fluorescent protein, using an IX-70 fluorescence microscope (Olympus).
Antibodies. Rabbit polyclonal antibodies against acetyl-histone H3 (catalog no. 06-599) and acetyl-histone H4 (catalog no. 06-866) and a mouse monoclonal antibody against RNA polymerase II (clone CTD4H8; catalog no. 05-0623) were obtained from Upstate. A rat monoclonal anti-HA antibody (clone 3F10) was purchased from Roche, and rabbit polyclonal anti-GFP antibodies (632459) were obtained from Clontech. Polyclonal antibodies specifically reacting with hDREF were raised against glutathione S-transferase-hDREF and affinity purified as described previously (26). Anti-rabbit immunoglobulin G (IgG) species-specific antibodies linked to horseradish peroxidase (NA934) were obtained from GE Healthcare Biosciences.
Western blotting. Cell lysates were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to an Immobilon-NC membrane (Millipore). Membranes were blocked with PBS containing 5% skim milk and 0.05% Tween 20 and incubated with the primary antibody. Secondary horseradish peroxidase-conjugated anti-rabbit IgG species-specific antibodies were used for detection with chemiluminescence reagent (ECL; GE Healthcare Biosciences).
BrdU labeling. Cells were plated at 2.6 x 103 cells/cm2 and transduced with each recombinant lentivirus as described in the figure legends. After each time point, cells were incubated in the presence of 15 µg/ml of bromodeoxyuridine (BrdU) (Roche) for 2 h. Detection of incorporated BrdU was performed as described previously (26). For each sample, at least 150 cells per field were counted and three fields were observed (total counted cell number was more than 500). The percentages of BrdU-positive cells in three fields were averaged.
Quantitative RT-PCR.
Total RNA was prepared from HFF cells by using an RNeasy mini kit (QIAGEN) according to the manufacturer's protocol. Total RNAs from synchronized WI38 cells, kindly provided by M. Fujita, were described previously (5). One microgram of RNA was subjected to synthesis of first-strand cDNAs with oligo(dT)20 primers and a recombinant Moloney murine leukemia virus reverse transcriptase (Invitrogen). PCRs were performed in 25 µl of reaction mixture containing 1x buffer II (Applied Biosystems), 1.25 mM MgCl2, 10 pmol of each of the gene-specific primer pairs, 200 µM each of dATP, dTTP, dCTP, and dGTP, 18.5 kBq [
-32P]dCTP, 0.1 U of AmpliTaq Gold (Applied Biosystems), and cDNA (1 µl of 30x diluted with H2O) as a template. The PCR included heating for 10 min at 95°C, followed by 20 cycles of 96°C for 30 s, 57°C for 30 s, and 72°C for 1 min to amplify quantitatively cDNAs for RPS6, RPL10A, RPL12, and the histone H1 gene. PCR for amplification of hDREF and ß-actin cDNA included 25 and 18 cycles, respectively, under the same reaction conditions. PCR products were separated on 6% polyacrylamide gels. After drying, images were taken using FLA-3000 (Fuji Film) and the amount of cDNA was quantified with the Image Gauge program (Fuji Film). For quantitative analysis, each primer set was used to generate a standard curve with serially diluted cDNA as a template.
In vivo protein synthesis. Cells were seeded to 12-well plates (3 x 104 cells/well) and, the next day, transduced with recombinant lentiviruses. After 48 h, they were washed once with PBS and then replenished with Dulbecco's modified Eagle's medium without methionine and cysteine (Invitrogen) supplemented with 10% dialyzed fetal calf serum, 2 mM glutamine, 100 U/ml penicillin, and 0.1 mg/ml streptomycin. One hour later, cells were labeled with 18.5 kBq of EXPRE35S35S (PerkinElmer) per well for 1 h and then washed with PBS containing methionine and cysteine (10 mM each). Cells were lysed in 200 µl of lysis buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% sodium deoxycholate, 0.1% Triton X-100, and 1% NP-40, and aliquots of 10 µl were taken for precipitation in 10% trichloroacetic acid (TCA) containing 10 mM each of methionine and cysteine. The precipitates were spotted onto filters (GF/C) and washed three times with 5% TCA and once with ethanol. After drying, filters were subjected to liquid scintillation counting and protein synthesis was calculated from TCA-insoluble counts per minute per 1 x 104 cells in each sample.
DNA transfection and luciferase assays. For luciferase assays, 3.5 x 104 HeLa cells were seeded in 24-well plates and cultured overnight. The next day, DNA-calcium phosphate precipitates containing a total of 1.5 µg of plasmids were added (42). The lack of plasmids was compensated for with an empty vector. At 4 h after addition of the precipitates, the precipitates were removed, and cells were cultured for 20 h in fresh medium. Firefly luciferase activities were measured using a dual luciferase reporter assay system (Promega) with a Lumat LB9501 luminometer (Berthold) and normalized to sea pansy luciferase activity by using pRL-TK (Promega). The assays were carried out in triplicate, and the averages are shown, together with standard deviations.
In vitro transcription/translation and EMSA. In vitro transcription/translation of hDREF was performed using pcDNA3-HA-hDREF as a template and a TNT T7 quick coupled transcription/translation system (Promega) according to the manufacturer's protocol. EMSA were performed as described previously (26), using in vitro-synthesized HA-hDREF proteins.
ChIP assays.
ChIP assays were performed based on a published protocol (36). HFF cells (0.8 x 107 cells) stably expressing HA-tagged hDREF were washed twice with PBS containing 2% fetal calf serum, suspended in 30 ml of PBS, and cross-linked with 1.1% formaldehyde for 5 min at room temperature. After termination of the cross-linking by addition of glycine to a final concentration of 0.125 M, cells were lysed with 3 ml of lysis buffer containing 50 mM Tris-HCl (pH 8.1), 5 mM EDTA, 1% sodium dodecyl sulfate, 1 mM sodium fluoride, 1 mM sodium orthovanadate, and protease inhibitors. Cell lysates were sonicated to yield chromatin fragments of
600 bp, as assessed by agarose gel electrophoresis, and then diluted 10-fold with dilution buffer (20 mM Tris-HCl [pH 8.1], 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 1 mM sodium fluoride, 1 mM sodium orthovanadate, and protease inhibitors). Diluted lysates were precleared by incubation with 20 µl of protein A-Sepharose and 20 µl of protein G-Sepharose (A/G mix; GE Healthcare Sciences) and sheared salmon sperm DNA. After centrifugation for 5 min at 7,000 x g, the supernatant was transferred to a fresh tube. One-tenth of the precleared lysate was subjected to immunoprecipitation by rocking overnight at 4°C with the appropriate antibody, and immune complexes were then precipitated with A/G mix and sheared salmon sperm DNA. Beads were collected by centrifugation and washed twice sequentially with Paro buffer I, Paro buffer II, Paro buffer III, and Tris-EDTA (27), and immunoprecipitates were eluted by adding 200 µl of elution buffer (1% sodium dodecyl sulfate, 0.1 M NaHCO3), followed by incubation at 65°C overnight. After centrifugation for 5 min at 7,000 x g, DNA was purified using a QIAGEN PCR purification kit. A 0.5-µl DNA sample was then subjected to quantitative amplification by use of gene-specific primer pairs.
|
|
|---|
gene promoter was used. For depletion experiments, we selected two target sequences (named si3 and si4) in the coding region of hDREF mRNA and constructed lentivirus expressing shRNA against hDREF mRNA under the control of the RNU6A gene promoter. We confirmed that more than 95% of the HFF cells were successfully transduced with lentivirus by a single exposure, as assessed by observing marker fluorescence protein expression (data not shown). Therefore, the transduced cells were directly used for experiments without any selection. Western blotting revealed that transduction with lentivirus overexpressing hDREF resulted in increase of hDREF protein (Fig. 1A, lanes 1 and 2), while expression of si4 and si3 shRNAs reduced the expression level to 35 and 41%, respectively, compared with controls (Fig. 1A, lanes 3, 4, and 5).
![]() View larger version (34K): [in a new window] |
FIG. 1. hDREF regulates human cell proliferation. (A) HFF cells were transduced with lentiviruses carrying an empty vector or expressing hDREF, scramble, si4, or si3 shRNA. Whole-cell extracts at 96 h after transduction were prepared, and protein samples were analyzed by immunoblotting using anti-hDREF antibodies (top). Consistent amounts of proteins loaded were confirmed by staining the transferred membrane with Ponceau dye (bottom). (B) Numbers of HFF cells transduced with lentiviruses carrying an empty vector or expressing hDREF were counted at 0, 48, and 96 h after transduction. Error bars represent the standard deviations with triplicate wells. Representative data from four independent experiments are shown. (C) Numbers of HFF cells transduced with lentiviruses expressing scramble shRNA or si3 and si4 shRNAs against hDREF mRNA. Error bars represent standard deviations with triplicate wells. Representative data from four independent experiments are shown. (D) Increase of BrdU-positive cells with overexpression of hDREF. HFF cells were transduced with lentiviruses carrying an empty vector or expressing hDREF. At 24, 48, 72, and 96 h after transduction, cells were labeled with BrdU for 2 h. Error bars represent the standard deviations with triplicate wells. (E) BrdU-positive cells were decreased by depletion of hDREF. HFF cells were transduced with the lentivirus expressing scramble shRNA or si4 shRNA. The time course and cell labeling with BrdU were the same as those described for panel D. (F) Images of BrdU-labeled HFF cells at 96 h after transduction with the indicated lentiviruses. (G) Rescue experimental design. (H) Whole-cell extracts at 72 and 120 h after the first transduction were prepared, and proteins were analyzed by immunoblotting using anti-hDREF antibodies (top). First-transduction efficiencies were confirmed by immunoblotting using anti-GFP antibodies to detect Venus proteins (bottom). (I) Numbers of HFF cells were counted at 72 and 120 h after the first virus transduction. Error bars represent the standard deviations with triplicate wells. Representative data of three independent experiments are shown.
|
hDRE-like sequences are present in the promoter regions of human RP genes. In order to identify novel target genes of hDREF, we performed a computational search of hDREF-binding sites in a database containing human promoter sequences (DBTSS [http://dbtss.bioinf.med.uni-goettingen.de/]). We found 208 genes carrying a sequence with more than an 8-bp match to 10 bp of the hDREF-binding consensus sequence [hDRE; 5'-TGTCG(C/T)GA(C/T)A-3'] within a 200-bp region upstream from the transcriptional start sites among 8,793 human genes. We noted that 22 out of 79 human RP genes possessed hDRE-like sequences in their promoter regions and that 20 of the relevant hDRE-like sequences were positioned at distances centered around 60 bp upstream of the putative transcriptional start sites (Table 1) . Despite several reports that disruption in one or more of the processes that control protein synthesis is associated with alteration in the cell cycle and cell growth in Saccharomyces cerevisiae (18, 19), the transcriptional regulation of mammalian RP genes in vivo remains unclear (28). Here, we first examined whether RP gene transcription is affected by depletion of hDREF. For this purpose, RPS6, RPL10A, and RPL12 were chosen as representative genes (Table 1).
|
View this table: [in a new window] |
TABLE 1. Human RP genes carrying hDRE-like sequence
|
![]() View larger version (34K): [in a new window] |
FIG. 2. Reduction of mRNA levels of RPS6, RPL10A, and RPL12 by hDREF depletion in HFF cells. (A) Total RNA was extracted from HFF cells transduced with lentiviruses expressing scramble shRNA or si4 shRNA against hDREF at 72 h after transduction. A representative gel image for three independent experiments is shown. The relative mRNA levels (RP/ACTB) were determined by densitometry, setting that for scramble as 1.0. Values and error bars in the right histogram represent the average values and standard deviations, respectively, for three independent experiments. (B) Decrease in protein synthesis by depletion of hDREF. HFF cells were transduced with lentiviruses expressing scramble shRNA or si4 shRNA. At 48 h after transduction, protein synthesis rates were measured in triplicate.
|
hDRE) was performed (Fig. 3D). Deletion of the hDRE-like sequence in the RPS6 promoter resulted in reduction of luciferase activity by 49% compared with that of the wild type and complete loss of the stimulation by coexpression of hDREF, indicating that hDREF stimulates luciferase gene expression dependent on the hDRE-like sequence in the RPS6 promoter.
![]() View larger version (22K): [in a new window] |
FIG. 3. hDRE-like sequences act as positive regulatory elements for RP gene promoter activities in vivo. (A) Decrease in promoter activities of RPS6, RPL10A, and RPL12 due to linker insertion mutations in hDRE-like sequences. HeLa cells were cotransfected with 1.4 µg of pGL3 basic vector (basic), wild-type, or linker insertion mutant reporter plasmids containing the indicated RP gene promoters and 0.1 µg of pRL-TK in single wells of 24-well plates. Representative data of two independent experiments are shown. (B) Decrease in promoter activity with base substitution mutations in the hDRE-like sequence of RPS6. HeLa cells were cotransfected with 1.4 µg of wild-type (wt) or base substitution mutant (mut1, -2, -3, -4, and -5) reporter plasmids containing the RPS6 promoter and 0.1 µg of pRL-TK in single wells of 24-well plates. Relative luciferase activities are shown, taking the activity of the wild-type RPS6 promoter as 1.0. Nucleotide sequences from 54 to 40 of the RPS6 promoter and its base substitution mutants are provided, with substituted nucleotides indicated by lowercase letters and sequences corresponding to that of hDRE boxed. Representative data from two independent experiments are shown. (C) Transactivation of the RP gene promoter by hDREF. HeLa cells were cotransfected with 1.0 µg of luciferase reporter plasmids carrying the indicated RP gene promoters (RPS6, RPL10A, and RPL12), 0.1 µg of pcDNA3-HA (hDREF) or pcDNA3-HA-hDREF (+hDREF), 0.1 µg of pRL-TK, and 0.3 µg of pCMX in single wells of 24-well plates. Representative data of two independent experiments are shown. (D) Transactivation of the RPS6 promoter by hDREF is dependent on the hDRE-like sequence. HeLa cells were cotransfected with 1.0 µg of luciferase reporter plasmids carrying the wild type or the hDRE-like sequence deletion mutant ( hDRE) of the RPS6 promoter, 0.2 µg of pcDNA3-HA (hDREF) or 0.1 µg of pcDNA3-HA-hDREF (+hDREF), 0.1 µg of pRL-TK, and 0.2 or 0.3 µg of pCMX in single wells of 24-well plates. Representative data of two independent experiments are shown.
|
![]() View larger version (81K): [in a new window] |
FIG. 4. Complex formation between the hDRE-like sequence in RPS6 and hDREF in vitro. EMSA analysis was performed using [32P]-labeled double-strand oligonucleotides containing histone H1-hDRE as a probe. The probe was incubated with reticulocyte lysate containing no hDREF protein (lane 2) or reticulocyte lysate containing hDREF protein (lanes 3 to 11). The following competitors were added to the binding reaction: no competitor (lanes 2 and 3), oligonucleotide containing H1-hDRE (lane 4) and its base substitution mutant (lane 5), and oligonucleotide containing RPS6-hDRE-like sequence (lane 6) and its base substitution mutants mut1, mut2, mut3, mut4, and mut5 (lanes 7 to 11). The probe was incubated with no reticulocyte lysate and no competitor (lane 1). Two arrowheads denote signals for complexes containing H1-hDRE and hDREF protein. wt, wild type.
|
![]() View larger version (24K): [in a new window] |
FIG. 5. hDREF binds to RP gene promoter regions containing hDRE-like sequences in vivo. (A) Whole-cell extracts of HFF cells transduced with lentiviruses expressing HA-tagged hDREF under the control of the human metallothionein gene promoter were prepared, and protein samples were analyzed by immunoblotting (IB) using anti-hDREF antibodies. Upper and lower bands correspond to exogenous HA-hDREF and endogenous hDREF, respectively. (B) Schematic illustration of the RPS6, RPL10A, and RPL12 genes. Arrowheads represent primers used for PCR. (C) ChIP analysis. PCR was performed using genomic DNA from the input extract and immunoprecipitates (IP) with control IgG and anti-HA, anti-acetylated histone H3, anti-acetylated histone H4, and anti-RNA polymerase II (pol II) antibodies.
|
![]() View larger version (39K): [in a new window] |
FIG. 6. Cell cycle-dependent fluctuation of hDREF and RP gene expression in WI38 cells. (A) Total RNA was extracted from asynchronous (lane 1) and synchronized (lanes 2 to 9) WI38 cells by use of a serum starvation method. RT-PCR was performed for hDREF, RPS6, RPL10A, RPL12, H1F0 (histone H1), and ACTB (ß-actin) genes. (B) Quantitative expression data. The relative mRNA levels for hDREF, RPS6, RPL10A, RPL12, and H1F0 (histone H1) were determined by densitometry, normalized to those for ß-actin, and plotted against time after serum addition. Values are given relative to the mRNA levels obtained using WI38 cells at 0 h after serum addition. Average values from three experiments are shown, with standard deviations.
|
![]() View larger version (59K): [in a new window] |
FIG. 7. Reduction of BrdU incorporation in HFF cells on depletion of the RPS6 gene. (A) Total RNA was extracted from HFF cells transduced with lentiviruses expressing scramble shRNA or RPS6-#1 or -#2 shRNAs against RPS6 at 96 h after transduction. RT-PCR was performed for RPS6 and ACTB (ß-actin). (B) HFF cells were transduced with lentiviruses expressing scramble shRNA or RPS6-#1 and -#2 shRNAs. At 48, 72, and 96 h after transduction, cell labeling with BrdU and detection were performed as described in the legend for Fig. 1D. (C) Images of BrdU-labeled HFF cells at 96 h after virus transduction.
|
|
|
|---|
In yeast, it has been demonstrated that deletions of only one of the RP genes can shut down ribosome production and affect critical cell size at the start phase, which occurs late in G1 phase (18). Studies using yeast showed that yeast RP genes are highly expressed in the cycling cells in rich medium but markedly and cooperatively down-regulated in response to a number of environmental stress conditions or during the transition from fermentation to respiration (39). The importance of mammalian RP genes in cell proliferation is clearly evidenced by the finding that adult liver cells of a knockout mouse conditionally deleted for rpS6 fail to proliferate after partial hepatectomy (38). As with yeast, although analyses of the regulation of transcription of mammalian RP genes have been carried out (28), the in vivo functional significance of transcriptional factors, such as GABP, Sp1, and YY1, remains obscure at present. For example, cell-free transcription analysis and EMSA have revealed that an element similar to the GABP-binding consensus sequence of RP genes acts as a positive element and that GABP could bind to the element (1, 43), but GABP binding in vivo has not been confirmed. Similarly, the in vivo contribution of YY1 sites seems obscure, because a functional significance for RP genes could not be demonstrated in a reporter assay (3, 31). hDRE-like sequences found in 22 human RP genes correspond to a sequence named "box A," one of the most conserved sequences among mammalian RP genes (28), which has been reported to be essential to drive the expression of the mouse rpL7a gene (2). However, this is the first report describing identification and characterization of a transcription factor binding to box A of mammalian RP genes in vivo. It should be emphasized that fluctuation of hDREF expression was here found to be in line with regulation of RP gene expression in a cell cycle-dependent manner.
Many reports have shown that the initiation of rRNA transcription is tightly linked to cell cycle progression and that synthesis of rRNA increases during G1 phase, reaches a maximal level in S and G2 phases, and is repressed in mitosis (7, 20, 22). We found that a 7 out of 10 match with the hDREF-binding sequence is located at the 108 position of the ribosomal DNA genes (26), raising a question of whether the ribosomal DNA genes are coordinately regulated by hDREF. However, the possibility was ruled out by results obtained from ChIP and RT-PCR analyses (data not shown).
We observed that almost all cells ceased proliferation on hDREF depletion associated with reduction in the expression of tested RP genes. We consider there are two possible explanations. The first is that the amount of RP synthesis, in other words, the capacity for protein synthesis in cells, may function as a critical and sensitive sensor to determine whether cells continue to proliferate. This seems likely because we observed that less than 50% depletion of RPS6 expression caused cell proliferation delay. Consistent with our findings,
uli
et al. have recently demonstrated that heterozygotic loss of rpS6 in T cells abrogates the T-cell proliferation normally accompanying receptor stimulation (35). Thus, it is likely that there is a novel checkpoint monitoring whether RP (or ribosome) synthesis is sufficient for continuing cell proliferation in mammals. The second possibility is that down-regulation of another unknown target gene(s) of hDREF may cause cell proliferation to cease. It is worth noting that we have also found hDRE-like sequences in promoter regions of genes required for cell cycle regulation (26), including CDC25C, CDC25A, CDK6, CCNC, CCND3, CCNG1, and CCNT1. Moreover, "M8" [5'-T(C/A)TCGCGAN(A/G)-3'], one of the best-conserved motifs recently found by systematic comparative genomics of the human genome, perfectly matches with hDRE (40). Although binding factors for the M8 motif have yet to be identified, hDREF is likely to recognize several included sequences. Interestingly, tissue-specific gene expression analysis revealed that genes containing M8 motifs exhibit enriched expression in proliferative hematopoietic cells, among 75 human tissues (40). Taking all of the available information into account, we propose that hDREF is involved in coordinating transcription of a subset of genes containing hDRE (or M8), including RP genes, which are related to cell proliferation and/or cell cycle progression. We are currently preparing genome-wide analyses including gene expression analysis by microarrays and ChIP-on-chip to obtain a comprehensive view of the potential target genes under the control of hDREF. Actually, we have performed a microarray-based expression profiling analysis and observed that several ribosomal protein genes were down-regulated by hDREF depletion (H. Osada, unpublished data).
hDREs are positioned at around 60 bp from the transcription start sites in 20 RP genes. Also, M8 motifs (a total of 368 copies in human promoter regions) tend to be present at distances centered at around 62 bp upstream of transcription start sites. Drosophila DRE has been described to exist at a similar position (the average distance to the ATG codon is estimated to be 168 bp) (24). We do not know the biological significance at present, but considering the fact that the Drosophila DREF/TRF2 complex directs core promoter recognition of the PCNA gene (15), we speculate that binding of hDREF at the 60 bp position may have an important role in sequestering uncharacterized factors such as components of the basal transcriptional machinery and initiating transcription. To elucidate this question, it will be necessary to identify factors or the protein complex associated with hDREF. We have already obtained evidence that endogenous hDREF exists in a high-molecular-weight complex in vivo (41a).
It is likely that Drosophila RP genes are under the regulation of the Drosophila DRE/DREF system for the following reasons. (i) Twenty-seven out of 77 Drosophila RP genes carry DREs in their promoters. (ii) Microarray analysis using probes prepared from Drosophila S2 cells depleting DREF revealed expression of some RP genes to be reduced (F. Hirose and A. Matsukage, unpublished data). (iii) Jasper et al. have identified a set of genes that are selectively expressed in the undifferentiated dividing cells but not in the terminally differentiated cells in the Drosophila eye imaginal disc (17). Interestingly, they found that 24 out of those 41 genes contain a perfectly matched or closely resembling DRE sequence within 1 kb of their transcriptional start site and that six RP genes (bonsai, mRpL5, RpP1, sop, RpP2, and RpL12) are included (17). (iv) Some responsibility for the Minute mutant, exhibiting delayed larval development, diminished viability, reduced body size, decreased fertility, and thin bristles, is believed to be carried by RP genes (6, 30). We have observed retarded development of Drosophila expressing an inverted-repeat RNA for the DREF gene in the whole body by use of a GAL4-UAS targeted system with the hsp70-GAL4 driver, resembling a Minute mutant-like phenotype (F. Hirose and M. Yamaguchi, unpublished data). Thus, regulation of RP gene expression, and therefore protein synthesis, might be a common feature of both Drosophila and human DRE/DREF systems, with effects on cell proliferation and cell cycle progression.
In summary, we here demonstrated that hDREF is an important transcriptional factor for cell proliferation involved in up-regulation of plural RP genes during the G1-to-S transition. We also provided evidence that insufficient expression of only one RP gene may impair cell proliferation.
This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) and the 21st Century COE Program. D.Y. was supported by a research fellowship from the JSPS for Young Scientists during the performance of the studies.
Published ahead of print on 12 January 2007. ![]()
|
|
|---|
and proliferating cell nuclear antigen. J. Biol. Chem. 268:2092-2099.
, J. R. Sharom, L. Schneper, J. R. Broach, and M. Tyers. 2004. A dynamic transcriptional network communicates growth potential to ribosome synthesis and critical cell size. Genes Dev. 18:2491-2505.
uli
, S., L. Pani
, M. Barki
, M. Mer
ep, M. Uzelac, and S. Volarevi
. 2005. Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response. Genes Dev. 19:3070-3082.
, S., M. J. Stewart, B. Ledermann, F. Zilberman, L. Terracciano, E. Montini, M. Grompe, S. C. Kozma, and G. Thomas. 2000. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science 288:2045-2047.
is negatively regulated by SUMO conjugation in the amino-terminal domain. Genes Cells 9:1017-1029.This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»